Tüdőrák: vizsgálatok itt: Egyesült Államok
901 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleDSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 20
- Run by
- Washington University School of Medicine
See details and how to joinNCT07545954 - 1. fázisTaking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Atlanta, Charlotte, Chicago, Cincinnati, Columbus, Duarte, Durham, Jacksonville, Louisville, Nashville, New Brunswick, New Haven, New York, Oklahoma City, Phoenix, Rochester, Sacramento, Seattle
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - 1/2. fázisTaking peoplePhase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
- Where
- Houston
- Életkor
- 18 év and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05039632 - No phaseTaking peopleCardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
- Where
- Columbia, New Brunswick, Rochester
- Életkor
- 18 év and over
- People
- 125
- Run by
- Bo Lu
See details and how to joinNCT06410300 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Atlanta, Boston, Duarte, Durham, Fairfax, Los Angeles, Nashville, Philadelphia, San Antonio, St Louis
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 2. fázisTaking peopleREStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
- Where
- Houston
- Életkor
- 18 év and over
- People
- 39
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05632809 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Birmingham, Boston, Grand Rapids, Houston, Jacksonville, Los Angeles, Palo Alto, Rochester, Seattle
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - 1. fázisTaking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Allentown, Dallas, Germantown, Hackensack
- Életkor
- 18 év and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771 - No phaseTaking peopleSignature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
- Where
- Glen Burnie
- Életkor
- 18 év and over
- People
- 750
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07008664 - No phaseNot yet taking people in Egyesült ÁllamokSymptom Management to Improve Completion of Patient-reported Outcome Measures
- Where
- Detroit
- Életkor
- 18 év and over
- People
- 78
- Run by
- Henry Ford Health System
See details and how to joinNCT07723495 - No phaseNot yet taking people in Egyesült ÁllamokA Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)
- Where
- Boston
- Életkor
- 18 év and over
- People
- 10
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07728773 - No phaseNot yet taking people in Egyesült ÁllamokAnalysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Where
- Oklahoma City
- Életkor
- 18 év and over
- People
- 2000
- Run by
- University of Oklahoma
See details and how to joinNCT07732686 - 1/2. fázisTaking peoplePeptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 12
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05950139 - 2. fázisTaking peopleStudy of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Where
- Detroit
- Életkor
- 18 év and over
- People
- 35
- Run by
- Bindu R Potugari
See details and how to joinNCT07339059 - 2. fázisTaking peopleA Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
- Where
- Omaha, Seattle
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Washington
See details and how to joinNCT05242965 - 2. fázisTaking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Baltimore, Boston, Indianapolis, Jacksonville, Lexington, Los Angeles, Miami, Mobile, New York, Phoenix, Richmond, Rochester, San Francisco, Tampa, The Bronx, Westwood
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseTaking peopleThe Florida ASCENT Study
- Where
- Gainesville
- Életkor
- 18 év to 100 év
- People
- 100
- Run by
- University of Florida
See details and how to joinNCT07042243 - 1. fázisTaking peoplePersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 28
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT05098210 - 1. fázisTaking peopleClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Baltimore, Columbus, Fairfax, Houston, Lexington, Louisville
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Birmingham, Cleveland, Dallas, Detroit, Fairfax, Farmington Hills, Fort Worth, Houston, Iowa City, Irvine, Orange, Richardson, Sacramento, San Antonio, West Valley City
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Aurora, Baltimore, Boston, Duarte, Grand Rapids, Houston, Irving, Kansas City, Nashville, Orlando, Phoenix, Rochester, Salt Lake City, San Antonio, Scottsdale, West Valley City
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 1. fázisTaking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Baltimore, Boston, Denver, Hackensack, Houston, Nashville, New York, Palo Alto, Philadelphia, Phoenix, Santa Monica, Sarasota
- Életkor
- 18 év and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - 2. fázisTaking peoplectDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
- Where
- Miami
- Életkor
- 18 év and over
- People
- 30
- Run by
- University of Miami
See details and how to joinNCT06902272 - 1/2. fázisTaking peopleNeoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
- Where
- New York
- Életkor
- 18 év and over
- People
- 21
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06088771 - No phaseTaking peopleDigital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
- Where
- Salt Lake City
- Életkor
- 50 év to 80 év
- People
- 800
- Run by
- University of Utah
See details and how to joinNCT07716280